Clinical Trials List
2024-11-01 - 2028-02-16
Phase II
Recruiting2
ICD-10N02.1
Recurrent and persistent hematuria with focal and segmental glomerular lesions
ICD-10N02.2
Recurrent and persistent hematuria with diffuse membranous glomerulonephritis
ICD-10N02.3
Recurrent and persistent hematuria with diffuse mesangial proliferative glomerulonephritis
ICD-10N04.1
Nephrotic syndrome with focal and segmental glomerular lesions
ICD-10N04.2
Nephrotic syndrome with diffuse membranous glomerulonephritis
ICD-9581.1
Nephrotic syndrome, with lesion of membranous glomerulonephritis
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 林維洲 無
- 陳怡婷 無
- 趙家德 無
- VIN-CENT Wu 無
- WEN-CHIH CHIANG 無
- 潘思宇 無
- SHUEI-LIONG LIN 無
- FAN-CHI CHANG 無
- 楊紹佑 無
- CHUN-FU LAI 無
- YU-HSIANG CHOU 無
- - - 無
- 黃道民 無
- - - 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
3 participants
-
Global
84 participants
